Cenra Inc. (TPE:3716)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.00
-0.25 (-0.71%)
At close: Jun 25, 2026

Cenra Company Description

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for prescription drugs, OTC products, health supplements, personal care products, and medical devices;home care, caregiver training, and consulting for elderly support; develops and manufactures veterinary pharmaceuticals, and animal health products for livestock and companion animals and offers CDMO services for animal health partners.

Cenra Inc. was founded in 2024 and is headquartered in Taipei, Taiwan.

Cenra Inc.
CountryTaiwan
Founded2024
IndustryMedical Distribution
SectorHealthcare
Employees542
CEOHou-Kai Wang

Contact Details

Address:
No. 23, Xiangyang Road
Taipei, 10046
Taiwan
Phone886 2 2312 4200
Websitecenra.com

Stock Details

Ticker Symbol3716
ExchangeTaiwan Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyTWD
SIC Code2834

Key Executives

NamePosition
Hou-Kai WangGeneral Manager and Director
Chih-Yung WuPresident
Chao-Lang LinDirector of Finance Department
Hui-Wen HsiaoAccounting Supervisor
Te-Feng ChaoDirector of Administrative Support Department
Teng-Pao LinChief Auditor
Yin-Nan SunVice President, Deputy GM and President of Chunghwa Yuming Healthcare Co Ltd